Their first product is the initial Clinical Decision Support software for personalized early diagnosis and treatment of lung cancer, utilizing Artificial Intelligence and Machine Learning applied to the world's largest clinical dataset.
The team consists of world-leading experts in medical imaging software, AI, and clinical practice, who came together at Oxford's renowned computer vision laboratory. Collectively, they have a proven track record of bringing innovation to market through over 10 start-up companies, resulting in 5 trade-sales and one IPO.

What we look for

Optellum is seeking to engage with hospital administrators, leaders in cancer, surgery, and other relevant service lines from regional medical systems, as well as thoracic surgeons and interventional pulmonologists from these institutions.